Showing results (421-430 of 447) with videos related to

Sort By:
Pageof 45
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 20, 2010
Defibrotide for the treatment of severe hepatic veno-occlusive disease and multiorgan failure after stem cell transplantation: a multicenter, randomized, dose-finding trialPaul G Richardson, Robert J Soiffer, Joseph H Antin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2006
Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group ReportHoward M Shulman, David Kleiner, Stephanie J Lee, et al.
Cell Reports|March 8, 2025
Haploinsufficiency of ITSN1 is associated with a substantial increased risk of Parkinson's diseaseThomas P Spargo, Chloe F Sands, Isabella R Juan, et al.
Brain : a Journal of Neurology|February 2, 2026
Mapping the causal chain from genetic risk variants to lipid dysmetabolism in Parkinson's diseaseRuth B De-Paula, Jonggeol Kim, Herve Rhinn, et al.
Biorxiv : the Preprint Server for Biology|March 23, 2026
Massive-scale single-nucleus multi-omics identifies novel rare noncoding drivers of Parkinson's diseaseShreya Menon, Adam W Turner, Serena H Chang, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 20, 2026
Rare heterozygous de novo variants in RAPGEF2 are associated with a neurodevelopmental disorderAli H Bereshneh, Kirkland A Wilson, Xueyang Pan, et al.
Brain : a Journal of Neurology|November 23, 2019
Genetic modifiers of risk and age at onset in GBA associated Parkinson's disease and Lewy body dementiaCornelis Blauwendraat, Xylena Reed, Lynne Krohn, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 7, 2022
Adverse Events Reported by Patients With Cancer After Administration of a 2-Dose mRNA COVID-19 VaccineRebecca M Shulman, David S Weinberg, Eric A Ross, et al.
Pageof 45